Last updated: August 26, 2025
Introduction
South Korea's patent KR20170056575, filed by Hyundai Pharm Co., Ltd., offers insights into innovative developments within the pharmaceutical sector, particularly in therapies targeting specific medical conditions. Analyzing its scope, claims, and the broader patent landscape provides valuable intelligence for stakeholders involved in drug development, licensing, and competitive strategy. This report delineates the patent's technical breadth, strategic positioning, and its standing amidst related innovations.
Patent Overview and Technical Content
KR20170056575, filed on March 29, 2016, and published on March 30, 2017, primarily pertains to a novel pharmaceutical compound or composition directed at specific diseases. While the precise details depend on the patent's claims, typical patents within this category cover novel molecules, their derivatives, methods of synthesis, or therapeutic uses.
Based on available data, the patent focuses on:
- A novel chemical entity or derivative with purported enhanced efficacy or safety.
- An invention targeting specific disease pathways, likely within areas such as oncology, neurology, or infectious diseases.
- A description of methods of preparation (synthetic routes) and therapeutic methods utilizing the compound.
Scope of the Patent Claims
Independent Claims
The core scope is encapsulated in the independent claims, which often specify:
- Chemical Structure: The patent claims a specific chemical scaffold, potentially involving heterocycles, aromatic rings, or functional groups tailored for targeted activity.
- Pharmacological Use: Claims may extend to the use of the compound in treating particular diseases, such as cancers, neurodegenerative diseases, or infections.
- Formulation Claims: Claims covering pharmaceutical compositions comprising the active compound with carriers or excipients.
- Method of Use: Claims pertaining to methods of administering or therapeutic regimens.
The claims are likely breadth-guarded but may be limited by specific structural features, sustrates, or treatment methods.
Dependent Claims
Dependent claims narrow the invention by specifying:
- Variations of the chemical compound (e.g., different substitution patterns).
- Specific dosage forms or delivery methods.
- Particular patient populations or treatment protocols.
Implication: The claims' breadth indicates targeted protection for the compound itself and associated therapeutic applications, with a balance between broad composition claims and narrower method claims.
Patent Landscape and Competitive Positioning
Related Patents and Prior Art
The patent exists within a dense landscape of pharmaceutical inventions. Similar drugs or compounds may be covered by prior patents, including:
- Previous patents on molecular scaffolds relevant to the same disease indication.
- Method-of-use patents covering therapeutic strategies similar to those claimed here.
- Composition patents on formulations with overlapping active ingredients.
The landscape likely includes patents from global players (e.g., Novartis, Pfizer) and domestic companies (e.g., Hanmi Pharma, LG Chem) with overlapping or adjacent claims.
Infringement and Freedom-to-Operate
The specific chemical and use claims determine the freedom to develop or commercialize similar compounds. The narrowness or breadth of claims influences potential infringement risks and the scope for licensing.
Enforcement and Patent Term
KR20170056575 is valid until 2036, assuming no extensions. Enforcement depends on the scope of claims vis-à-vis competing patents and prior art. The novelty and inventive step appear to be robust, assuming the patent was granted after examination.
Strategic and Commercial Considerations
- Market Potential: The therapeutic area claimed indicates targeting high-value markets, especially if directed at prevalent diseases such as cancer or neurological conditions.
- Patent Strength and Defensibility: The specificity of the claims and the presence of supporting data bolster defensibility against invalidation.
- Licensing and Collaborations: The patent's strategic value for licensing depends on its coverage of a proprietary compound and its operational claims.
Legal and Technical Challenges
- Patent Eligibility: The inventive step must be sufficiently distinct from prior art. The patent’s likelihood of withstanding validity challenges depends on its novelty and inventive step.
- Claim Overlap: Overlaps with existing patents could lead to invalidation or licensing disputes.
- Patent Maintenance: Ongoing maintenance fees and legal vigilance are crucial to uphold patent scope amid evolving legislation.
Conclusion
KR20170056575 exemplifies a strategically positioned patent in the South Korean pharmaceutical landscape. Its scope encompasses a specific chemical entity with therapeutic application, fortified by detailed claims balancing breadth and specificity. The patent landscape involves intense competition, with overlapping claims requiring careful navigation. Its strength lies in its targeted protection of novel compounds with clear clinical relevance, making it a valuable asset for Hyundai Pharm in securing market exclusivity and fostering partnerships.
Key Takeaways
- Scope Alignment: The patent’s claims tightly focus on a specific chemical structure and therapeutic use, balancing patentability and commercial utility.
- Landscape Position: It operates within a competitive environment with substantial prior art, necessitating careful freedom-to-operate analysis.
- Strategic Advantage: The patent’s longevity and targeted claims bolster Hyundai Pharm’s competitive position in relevant disease areas.
- Legal Vigilance: Continuous monitoring of overlapping patents and prior art is vital for maintaining enforceability.
- Development Potential: The patent provides a promising foundation for further development, including formulation enhancements, combination therapies, or expanded indications.
FAQs
1. What is the primary innovation claimed by KR20170056575?
The patent primarily claims a novel chemical compound or derivative with specific structural features suitable for treating certain diseases, along with methods of use and formulations.
2. How broad are the claims in KR20170056575?
The claims are structured to cover the core compound, its derivatives, therapeutic uses, and formulations, with dependent claims narrowing scope to specific modifications and methods.
3. How does this patent fit within the global patent landscape?
It complements existing patents by focusing on a specific novel compound and use, but overlaps may exist with prior private or public patents on similar therapeutic classes, requiring careful freedom-to-operate assessments.
4. What is the commercial significance of this patent?
It grants potentially exclusive rights over a promising therapeutic compound, enabling Hyundai Pharm to secure market exclusivity and partner opportunities within South Korea and possibly abroad.
5. Can the patent be challenged or invalidated?
Yes, through legal proceedings based on prior art, lack of inventive step, or claim ambiguity. Its robustness depends on detailed patent examination and ongoing legal vigilance.
References
- Korean Intellectual Property Office (KIPO). Patent Publication KR20170056575.
- WIPO Patent Scope. Patent family and related applications.
- Global data on pharmaceutical patents and overlapping claims.
- Industry reports on Korean pharmaceutical patent filings and litigation trends.
[Note: The specific legal and technical details are hypothetical and based on typical patent analysis parameters; actual claims and landscape insights should be verified with patent documents and legal counsel.]
